Fierce Biotech Week 2027
Fierce Biotech Week is a conference for biotech and pharma leaders. It draws C-suite executives and founders, R&D and clinical heads, business development teams and outsourcing partners.
Monday to Wednesday · 3 days
Organizer
Published by the organizer
Every year
How often it's held
Checked November 3, 2026
Reported attendance
1,400+
attendees · year not stated
Reported exhibitors
Not published
About Fierce Biotech Week 2027
Fierce Biotech Week is a three-day conference for biotech and pharma leaders, run by Questex's Fierce Life Sciences events team. It covers drug development, clinical operations and trial master files, business development and licensing, and communications. The next edition runs 17 to 19 May 2027 in Boston, and the organizer hasn't named the 2027 venue yet. The organizer's sponsor page cites 1,400+ attendees, 220+ speakers and 50+ sponsors.
500+
Companies represented
300+
C-suite executives
70%
Director level and above
45
Investment firms
220+
Speakers
50+
Sponsors
What happens at Fierce Biotech Week
Fierce Biotech Week is a conference with a small exhibit area, built around four community tracks. The 2026 agenda ran 100 sessions over 12 to 14 May, by our count of the official agenda.
The tracks were Drug Development, Clinical and TMF, BD&L, and PR and Communications. Shared sessions, networking lunches and receptions sat alongside them.
The Fierce Outsourcing Awards are part of the week. They were formerly the Fierce CRO Awards and honor CROs, CDMOs and other drug development partners. The 2026 winners included Medable, Cellares, Caidya and AGC Biologics, celebrated on 13 May.
The organizer also runs a networking app with AI matchmaking and one-to-one meetings. Meetings are open to pharma, biotech, agency and partner registrants, but not to vendors.
What's new for 2027
The main confirmed change for 2027 is the date, 17 to 19 May 2027, later in May than in 2026. The organizer has opened 2027 partner opportunities and a mailing list for 2027 updates. It hasn't announced the 2027 venue, program or speakers.
Who attends Fierce Biotech Week
Fierce Biotech Week draws senior biotech and pharma decision makers, from director level to the C-suite. The organizer's who-attends page cites 500+ companies, 300+ C-suite executives and 45 investment firms. It also says 70% of attendees are director level or above, and that 15+ top global pharma companies take part.
- C-level, EVP, SVP, VP50%
- Director20%
- Manager8%
- Other22%
Organizer's 2027 partner page, 530+ drug development leaders community. The page doesn't give a year.fiercebiotechweek.com ↗
- C-level, EVP, SVP, VP76%
- Director16%
- Manager3%
- Other5%
Organizer's 2027 partner page, 380+ BD&L executives community. The page doesn't give a year.fiercebiotechweek.com ↗
- C-level, EVP, SVP, VP25%
- Director37%
- Manager20%
- Other18%
Organizer's 2027 partner page, 350+ clinical and TMF professionals community. The page doesn't give a year.fiercebiotechweek.com ↗
- C-level, EVP, SVP, VP42%
- Director36%
- Manager10%
- Other12%
Organizer's 2027 partner page, 120+ PR and communications community. The page doesn't give a year.fiercebiotechweek.com ↗
The about page lists biotech and pharma executives, R&D, clinical and regulatory leaders, and BD&L teams. Investors, strategic partners and emerging biotech founders also attend.
The 2027 partner page breaks the audience into four communities with job-level splits. It counts 530+ drug development leaders, 380+ BD&L executives, 350+ clinical and TMF professionals and 120+ PR and communications people. The BD&L group is the most senior, with 76% at C-level, EVP, SVP or VP. None of these figures carries a year.
Figures differ between pages. The about page cites 1,000+ attendees, 100+ speakers and 75+ sessions, while the sponsor page cites 1,400+ attendees.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| Not stated | 1,400+attendeesFrom the organizer's 2027 partner page, which gives no year. The about page cites 1,000+ attendees.fiercebiotechweek.com ↗ |
Companies sponsoring, exhibiting and attending Fierce Biotech Week 2026
The organizer's 2026 partners page names 33 sponsors in five tiers and 14 exhibitors, by our count on 3 November 2026. IQVIA, RevHealth and Syneos Health were the Diamond partners.
Sponsors (32)IQVIA, RevHealth, Syneos Health and 29 more
- IQVIA · 2026Diamond partner in 2026
- RevHealth · 2026Diamond partner in 2026
- Syneos Health · 2026Diamond partner in 2026
- Parexel · 2026Platinum partner in 2026
- PhaseV · 2026Platinum partner in 2026
- TrialWire · 2026Platinum partner in 2026
- IPM · 2026Platinum partner in 2026
- Alphanumeric · 2026Gold partner in 2026
- Cooley · 2026Gold partner in 2026
- GCI Health · 2026Gold partner in 2026
- H1 · 2026Gold partner in 2026
- Medable · 2026Gold partner in 2026
- Ropes & Gray · 2026Gold partner in 2026
- Egnyte · 2026Silver partner in 2026
- HSBC Innovation Banking · 2026Silver partner in 2026
- ICR Healthcare · 2026Silver partner in 2026
- IDT Australia · 2026Silver partner in 2026
- Life Science Sherpas · 2026Silver partner in 2026
- Mintz · 2026Silver partner in 2026, and sponsor of the Life Science Sherpas Reception
- New York Stock Exchange · 2026Silver partner in 2026
- Varda Space Industries · 2026Silver partner in 2026
- William Blair · 2026Silver partner in 2026
- Annovis Bio · 2026Bronze partner in 2026
- Ferma (ZoomRx) · 2026Bronze partner in 2026
- FIS · 2026Bronze partner in 2026
- Freshfields · 2026Bronze partner in 2026
- Harbor Clinical · 2026Bronze partner in 2026
- Lonza · 2026Bronze partner in 2026
- Premier Research · 2026Bronze partner in 2026
- ProofPilot · 2026Bronze partner in 2026
- SanaClis · 2026Bronze partner in 2026
- Simulations Plus · 2026Bronze partner in 2026
Exhibitors (14)Agatha, Ardena, Bend Bio and 11 more
- Agatha · 20262026 exhibitor
- Ardena · 20262026 exhibitor
- Bend Bio · 20262026 exhibitor
- Brand Institute · 20262026 exhibitor
- Dot Compliance · 20262026 exhibitor
- Finsight Group · 20262026 exhibitor
- InfoVision · 20262026 exhibitor
- Julius Clinical · 20262026 exhibitor
- MyData-TRUST · 20262026 exhibitor
- Onyx Scientific · 20262026 exhibitor
- RxAccess Partners · 20262026 exhibitor
- Scout Clinical · 20262026 exhibitor
- SS&C Intralinks · 20262026 exhibitor
- Suvoda · 20262026 exhibitor, booth 114
Attending (13)Evotec, Amgen, AstraZeneca and 10 more
- Evotec · 2025Attended the October 2025 edition in Boston
- AmgenNamed on the organizer's who-attends page, edition not given
- AstraZenecaNamed on the organizer's who-attends page, edition not given
- Bristol Myers SquibbNamed on the organizer's who-attends page, edition not given
- Gilead SciencesNamed on the organizer's who-attends page, edition not given
- ModernaNamed on the organizer's who-attends page, edition not given
- NovartisNamed on the organizer's who-attends page, edition not given
- PfizerNamed on the organizer's who-attends page, edition not given
- SanofiNamed on the organizer's who-attends page, edition not given
- TakedaNamed on the organizer's who-attends page, edition not given
- Vertex PharmaceuticalsNamed on the organizer's who-attends page, edition not given
- Andreessen HorowitzNamed on the organizer's who-attends page, edition not given
- Flagship PioneeringNamed on the organizer's who-attends page, edition not given
Sponsors are mostly CROs, clinical technology firms, law firms, banks and agencies. Big pharma and biotech companies mostly come as attendees and speakers. The who-attends page names Amgen, AstraZeneca, Pfizer, Takeda and Vertex Pharmaceuticals among participating organizations, without saying which edition.
Companies also confirm their own presence. Suvoda exhibited at booth 114 in 2026, and Mintz sponsored the Life Sciences Sherpas Reception. Evotec attended the October 2025 edition, as did Simulations Plus.
Exhibitors at Fierce Biotech Week
Fierce Biotech Week has a modest exhibit area, with 14 exhibitors on the 2026 partners page, by our count. Exhibitors were mostly clinical service, data, compliance and CDMO firms.
The organizer's sponsorship page offers exhibition space, demo stations, 10x10 booths and large lounges. It doesn't publish booth prices, so you'll need to contact the sales team.
Exhibitors use the event app to qualify and score leads and export contacts after the show. Compare tools for this in our guide to lead retrieval apps.
Sponsors and partners at Fierce Biotech Week
Fierce Biotech Week sells sponsorship in Diamond, Platinum, Gold, Silver and Bronze tiers, shown on the 2026 partners page. IQVIA, RevHealth and Syneos Health topped the 2026 list.
The 2027 partner opportunities page lists booth packages, thought leadership slots, branding, activations and private meals. It also sells digital media across Fierce newsletters, websites and video interviews.
Sponsored sessions feed the organizer's session takeaways on the home page. Our roundup of event sponsorship software covers tools for managing these deals.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
Fierce Biotech Week attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
The official exhibitor and sponsor list is the 2026 partners page. It shows logos by tier, linked to each company's site.
The organizer doesn't publish or sell an attendee list. Its FAQ warns that emails offering attendee lists are fraud and says Questex doesn't sell personal data.
Registered attendees can browse other attendees inside the event app, which offers matchmaking. The who-attends page names participating companies and typical job titles.
For other ways to see who's going, read how to find who's attending an event. Our guide to event intelligence platforms compares the data tools.
See who's attending Fierce Biotech Week
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at Fierce Biotech Week 2027
Fierce Biotech Week hasn't announced its 2027 speakers yet. The speaker page still shows the 2026 lineup, and the organizer takes proposals through its call for speakers.
Fierce Biotech Week hasn't announced its 2027 speakers yet. Below is who spoke at past editions.
At the 2026 edition, the agenda listed 167 speakers and moderators, by our count. Corsera Health co-CEO John Maraganore spoke on RNAi in a fireside chat. United Therapeutics CEO Martine Rothblatt joined a panel on drug development in orbit.
Other 2026 speakers came from Takeda, Bristol Myers Squibb, Ipsen, Novo Nordisk, Amgen, Merck, Biogen and Bayer. Investors and bankers from Andreessen Horowitz, Flagship Pioneering, BMO Capital Markets and the New York Stock Exchange also spoke.
Speaking slots are earned for people at pharma, biotech, medical device, diagnostics and advocacy groups. Sponsors get speaking spots through partnership packages.
Who spoke at Fierce Biotech Week 2026 (48)
- John Maraganore, PhD, Founding and Co-CEO, Corsera Health. CEO and Principal, JMM Innovations, Corsera Health
- Martine Rothblatt, Founder, Chairperson, and CEO, United Therapeutics
- Christopher Arendt, Chief Science Officer, Head of Research, Takeda
- Manisha Desai, Senior Vice President, Product Development, Product Development & Supply, Bristol Myers Squibb
- Christelle Huguet, Executive Vice President, Head of R&D, Ipsen
- Paul Bolno, President & CEO, Wave Life Sciences
- Kristen Fortney, PhD, Co-Founder & CEO, BioAge Labs
- Brian Alexander, MD, MPH, CEO, Valo Health
- Abbas Kazimi, Chief Executive Officer, Nimbus Therapeutics
- Narimon Honarpour, MD, PhD, Senior Vice President, Global Development, Amgen
- Jacob Petersen, Senior Vice President, Global Research in Research and Development, Novo Nordisk
- Scott Dewire, Corporate Senior Vice President & Head of Global Business Development, Boehringer Ingelheim
- Kendra Rose, Senior Vice President, BD&L, Bayer
- Adam Keeney, Executive Vice President and Head of Corporate Development, Biogen
- Eric Olson, Chief Business Officer & Executive Vice President, Ultragenyx
- Lizabeth Leveille, Vice President, BD&L and Head, Boston Innovation Hub & Discovery Transactions, Merck
- Jessica Kirshner, Vice President of Oncology and Immuno-Oncology, Regeneron
- Anthony Jarkowski, Senior Vice President, Primary Focus Lead, Head of Immuno-Oncology, Astellas Pharma
- Moitreyee Chatterjee-Kishore, Head of Oncology Development, Astellas Pharma Inc.
- Diana Gallagher, MD, SVP, Head of Clinical Development for MS, Immunology and Alzheimer's, Biogen
- Canwen Jiang, Chief Development Officer & Chief Medical Officer, AskBio
- Juliet Williams, PhD, Head of Research, Kymera
- Peter Tummino, President of Research & Development, Nimbus Therapeutics
- Jennifer McCafferty, PhD, Senior Vice President, Head of CMC-Regulatory and MRL Quality Assurance, Merck
- Ryan Kelly, Chief Communications Officer, Recursion
- Kate O'Malley, Vice President, Corporate Affairs, Moderna
- Sue Hager, Advisory Partner, Andreessen Horowitz
- Nathan Jorgensen, Growth Partner, Flagship Pioneering
- Uli Stilz, Senior Advisor, Flagship Pioneering
- Evan Seigerman, Managing Director, Head of Healthcare Research BioPharma & Biotechnology, BMO Capital Markets
- Maha Radhakrishnan, Executive Partner, Private Equity, Sofinnova Investments
- Eric Dimise, Director, Healthcare & Life Sciences, Capital Markets, New York Stock Exchange
- Venkat Ramanan, Chief Financial Officer, Immatics
- Michael Reilly, Chief Strategy Officer, Varda Space Industries
- Kellie Malloy Foerter, VP, Global Trial Management, Bristol Myers Squibb
- Priya Chaturvedi, VP, Head of Global Clinical Quality, Eisai
- Jamie Harrop, Vice President Clinical Operations, Beam Therapeutics
- Dennis Salotti, Executive Director & Head, Clinical Outsourcing & Site Operations, Jazz Pharmaceuticals
- Rebecca Halbur, Associate Director, TMF Records Management, Clinical Trial Systems & Operations, Moderna
- Nikhil Mutyal, Head of Search and Evaluation - Respiratory & Immunology, AstraZeneca
- Frédéric Scaerou, Head of Global Business Development, Servier
- Gadi Bornstein, Senior Director, External Innovation, Johnson & Johnson Innovative Medicine
- Anu Connor, Vice President, Head of Oncology Search and Evaluation, Ipsen
- Carla Bauer, Director, Oncology Search and Evaluation, Business Development & Licensing, Merck
- Kelly Gold, CFO, CAMP4 Therapeutics
- Tori Fort, SVP, Corporate Strategy and Corporate Affairs, Ovid Therapeutics
- Ben Bradford, Head of External Affairs, MassBio
- Eric Blanchard, Partner, Cooley LLP
Dates, venue and getting there
Fierce Biotech Week 2027 runs 17 to 19 May 2027 in Boston. Forge, the parent of Questex, lists the same dates in its event calendar.
The organizer hasn't named a 2027 venue yet. The 2026 edition took place at Encore Boston Harbor in Everett, just north of Boston.
The Encore Boston Harbor resort served as the official hotel in 2026, with a discounted room block. Sessions ran in its Picasso meeting rooms.
Tickets and registration for Fierce Biotech Week
Fierce Biotech Week is a paid professional event, and pass prices depend on your type of company. The registration page still shows 2026 rates, checked in November 2026. The organizer hasn't posted 2027 prices.
In 2026 the final rate was $1,395 for biopharma and investment leaders. Strategic partners such as CROs, CDMOs, law firms and agencies paid $2,195. Technology and solution providers paid $3,895.
Group discounts ran from 15% for two to four people to 25% for ten or more. They didn't apply to vendor passes.
The registration FAQ sets eligibility by job title and company. Sales and business development staff at service firms must buy the vendor pass. Qualifying drug developers and investors could get a free pass from 22 December 2025 to 31 January 2026.
History of Fierce Biotech Week
Questex launched Fierce Biotech Week for 2025, merging three older events. Its October 2024 announcement says it combined the Fierce Biotech Summit, Trial Master File Summit and Fierce Clinical Summit.
The first edition ran 7 to 9 October 2025 in Boston. The event then moved to May, with the 2026 edition held 12 to 14 May at Encore Boston Harbor.
Questex now describes itself as a Forge company. Related events on this site include BIO International Convention 2027 and Biotech Showcase 2027.
Resources for exhibitors, sponsors and attendees
These official pages cover registration, sponsorship and planning.
- Registration and pass pricesWith eligibility rules by company type
- Registration FAQCovering passes, press, hotel and the attendee list warning
- 2027 partner opportunitiesWith audience figures and sponsorship formats
- Become a partnerThe sponsorship and exhibit enquiry page
- 2026 partners and exhibitorsThe official sponsor and exhibitor list
- Who attendsWith participating companies and job titles
- 2026 agendaThe full session program by track
- 2026 speakersThe latest published lineup
- Call for speakersFor speaking proposals
- Event appWith attendee and exhibitor guides
- Fierce Outsourcing AwardsThe awards program held during the week
- Venue and hotelWith 2026 venue and hotel details
- Code of conductThe attendee rules for Fierce Life Sciences events